Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Acid Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthesis method offers high enantioselectivity and significant cost reduction for chiral catalyst manufacturing supply chains globally ensuring reliable pharmaceutical intermediates
Patent CN116063223A reveals a metal-free TfOH catalyzed route for 10-perfluoroalkyl-5,10-dihydroindeno[1,2-b]indoles, offering high yields and scalable manufacturing for pharmaceutical intermediates.
Novel synthesis route avoids explosive diazo compounds, offering high purity and scalable production for pharmaceutical intermediates globally.
Patent CN113735867B reveals high-yield chiral synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN117820316B reveals efficient chiral phosphoric acid catalysis for high-purity antitumor intermediates, offering significant cost reduction and supply reliability.
Patent CN107382741B details a high-yield B(C6F5)3 catalyzed hydroamination. Offers cost-effective, scalable routes for pharmaceutical intermediates with minimal impurities.
Novel chiral indole synthesis method offers high yield and enantioselectivity for pharmaceutical intermediates, ensuring cost reduction and supply reliability.
Novel patent CN119504713A reveals efficient synthesis of indole-pyrrole tetraarylmethane. Offers cost reduction and scalable supply for pharmaceutical intermediates.
Novel chiral phosphoric acid catalysis enables high-yield indolocyclopentanes synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN115385916B details chiral phosphoric acid catalysis for high-purity pharmaceutical intermediates. Enables cost reduction in pharmaceutical intermediates manufacturing with scalable processes.
Patent CN113735867B reveals high-yield chiral synthesis for anticancer leads. Offers cost reduction in API intermediate manufacturing and supply chain reliability.
Novel protonic acid catalysis enables cost reduction in pharmaceutical intermediates manufacturing with high purity and scalable supply chain reliability.
Patent CN110452150A reveals a novel one-step synthesis for axial chiral indole-naphthalene compounds offering high purity and significant supply chain cost advantages.
Novel chiral phosphoric acid catalysis enables high-purity pharmaceutical intermediates with reduced costs and scalable production for global supply chains.
Novel chiral phosphoric acid catalyzed synthesis offers high yield and selectivity for anticancer intermediates ensuring supply chain stability.
Patent CN104520275B details a novel route for 4-oxoquinolone compounds, offering improved stability and cost-effective manufacturing for HIV integrase inhibitor supply chains.
Patent CN114524701B reveals efficient chiral phosphoric acid catalysis for high-purity pharmaceutical intermediates with superior cytotoxicity against QGP-1 tumor cells.
Novel chiral phosphoric acid catalyzed synthesis of indolocyclopentanes with high enantioselectivity. Cost-effective route for pharmaceutical intermediates targeting PC-3 cancer cells.
Patent CN118878543A reveals high-purity axial chiral synthesis. Delivers significant cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Novel chiral phosphoric acid catalyzed synthesis offers high optical purity and mild conditions for scalable pharmaceutical intermediate manufacturing and supply chain optimization.